Treatment of inflammatory diseases using placental stem cells
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-035/50
A61K-038/21
C12N-005/073
A61K-045/06
A61K-035/64
A61K-035/12
출원번호
US-0891732
(2013-05-10)
등록번호
US-8916146
(2014-12-23)
발명자
/ 주소
Edinger, James W.
Hariri, Robert J.
Wang, Jia-Lun
Ye, Qian
Faleck, Herbert
출원인 / 주소
Anthrogenesis Corporation
대리인 / 주소
Jones Day
인용정보
피인용 횟수 :
0인용 특허 :
208
초록▼
Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin sy
Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin syndrome), or scleroderma using placental stem cells or umbilical cord stem cells.
대표청구항▼
1. A method of treating an individual having inflammatory bowel disease, comprising administering to the individual a therapeutically effective amount of non-hematopoietic placental stem cells, wherein said placental stem cells are CD10+,CD34−, CD105+, CD200+, and CD117−as detectable by flow cytomet
1. A method of treating an individual having inflammatory bowel disease, comprising administering to the individual a therapeutically effective amount of non-hematopoietic placental stem cells, wherein said placental stem cells are CD10+,CD34−, CD105+, CD200+, and CD117−as detectable by flow cytometry, and wherein the therapeutically effective amount is an amount sufficient to cause a detectable improvement in one or more symptoms of said inflammatory bowel disease. 2. The method of claim 1, wherein said inflammatory bowel disease is ulcerative colitis. 3. The method of claim 1, wherein said inflammatory bowel disease is Crohn's disease. 4. The method of claim 3, wherein said Crohn's disease is gastroduodenal Crohn's disease, jejunoileitis, ileitis, ileocolitis, or Crohn's colitis. 5. The method of claim 1, wherein said symptom is one or more of diarrhea, abdominal pain, inflammation and swelling of a part of the gastrointestinal tract, formation of scar tissue in the intestines, formation of sores or ulcers in the intestine, development of one or more fistulas in the intestinal wall, or development of one or more fissures in the anus. 6. The method of claim 3, wherein said symptom is one or more of diarrhea, abdominal pain, inflammation and swelling of a part of the gastrointestinal tract, formation of scar tissue in the intestines, formation of sores or ulcers in the intestine, development of one or more fistulas in the intestinal wall, or development of one or more fissures in the anus. 7. The method of claim 5, wherein said symptom is development of one or more fistulas in the intestinal wall or development of one or more fissures in the anus. 8. The method of claim 6, wherein said symptom is development of one or more fistulas in the intestinal wall or development of one or more fissures in the anus. 9. The method of claim 1, comprising administering a second therapeutic agent to said individual. 10. The method of claim 9, wherein said second therapeutic agent is one or more of an anti-inflammatory agent, an immunosuppressant compound, a steroid, or an antibiotic. 11. The method of claim 3, comprising administering a second therapeutic agent to said individual. 12. The method of claim 11, wherein said second therapeutic agent is one or more of an anti-inflammatory agent, an immunosuppressant compound, a steroid, or an antibiotic. 13. The method of claim 1, wherein about 1×105, 5×105, 1×106, 5×106, 1×107, 5×107, 1×108, or 5×108 placental stem cells are administered or wherein between 1 million and 10 billion placental stem cells are administered. 14. The method of claim 3, wherein about 1×105, 5×105, 1×106, 5×106, 1×107, 5×107, 1×108, or 5×108 placental stem cells are administered or wherein between 1 million and 10 billion placental stem cells are administered. 15. The method of claim 4, wherein about 1×105, 5×105, 1×106, 5×106, 1×107, 5×107, 1×108 , or 5×108 placental stem cells are administered or wherein between 1 million and 10 billion placental stem cells are administered. 16. The method of claim 1, wherein said placental stem cells are administered directly into an organ. 17. The method of claim 2, wherein said placental stem cells are administered directly into an organ. 18. The method of claim 3, wherein said placental stem cells are administered directly into an organ.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (208)
Hon-Wah Man ; George W. Muller, 1-oxo-and 1,3-dioxoisoindolines.
Kois,Adam; MacFarlane,Karen J.; Satoh,Yoshitaka; Bhagwat,Shripad S.; Parnes,Jason S.; Palanki,Moorthy S. S.; Erdman,Paul E., Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto.
Kois,Adam; MacFarlane,Karen J.; Satoh,Yoshitaka; Bhagwat,Shripad S.; Parnes,Jason S.; Palanki,Moorthy S. S.; Erdman,Paul E., Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto.
Kuypers Franciscus A. ; Cole Robert B. ; Meyst Richard P. ; Gorton Lanny A. ; Wright James I., Apparatus and method for collecting blood from an umbilical cord.
Kuypers Franciscus A. ; Cole Robert B. ; Meyst Richard P. ; Gorton Lanny A. ; Wright James I., Apparatus and method for collecting blood from an umbilical cord.
Kuypers Franciscus A. ; Cole Robert B. ; Meyst Richard P. ; Gorton Lanny A. ; Wright James I., Apparatus and method for collecting blood from an umbilical cord.
Capecchi Mario R. (Salt Lake City UT) Thomas Kirk R. (Salt Lake City UT), Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and.
Capecchi Mario R. (Salt Lake City UT) Thomas Kirk R. (Salt Lake City UT), Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and.
Heidaran, Mohammad; Wang, Jia-Lun; Ye, Qian; Zeitlin, Andrew; Dulaney, Colleen Suzanne, Co-culture of placental stem cells and stem cells from a second source.
Emerson Stephen G. (Ann Arbor MI) Clarke Michael F. (Ann Arbor MI) Palsson Bernhard O. (Ann Arbor MI), Compositions containing cultured mitotic human stem cells.
Caplan Arnold I. ; Haynesworth Stephen E. ; Gerson Stanton L. ; Lazarus Hillard M., Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells.
Bauer S. Christopher ; Abrams Mark Allen ; Braford-Goldberg Sarah Ruth ; Caparon Maire Helena ; Easton Alan Michael ; Klein Barbara Kure ; McKearn John Patrick ; Olins Peter O. ; Paik Kumnan ; Thomas, Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines.
Bjornson Christopher R. ; Rietze Rod L.,AUX ; Reynolds Brent A.,CAX ; Vescovi Angelo L.,ITX, Generation of hematopoietic cells from multipotent neural stem cells.
Nakahata Tatsutoshi (Matsumoto JPX) Kawano Genji (Kamakura JPX) Sudo Tetsuo (Kamakura JPX) Kojima Katsuaki (Yokohama JPX), Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a grow.
Rubinstein Pablo ; Coelho Philip Henry ; Stevens Cladd E., High concentration white cells, a method for agglomeration of the high concentration and a bag set for use in conjuncti.
Janice M. Davis-Sproul ; Mark Aaron Moorman ; Renee Marie McNeil ; Donald William Simonetti, Jr. ; Lora Catherine Hammill ; Stewart Craig, Human mesenchymal stem cells.
Srour Edward (Indianapolis IN) Zanjani Esmail (Reno NV) Brandt John E. (Indianapolis IN) Hoffman Ronald (Indianapolis IN), Human stem cell compositions and methods.
Tsukamoto Ann (Palo Alto CA) Baum Charles M. (Mountain View CA) Aihara Yukoh (Yokohama JPX) Weissman Irving (Palo Alto CA), Identification and isolation of human hematopoietic stem cells.
Johnson R. Paul (Lexington MA) Rosenzweig Michael (Boston MA) Scadden David T. (Weston MA), In vitro differentiation of CD34+progenitor cells into T lymphocytes.
Cameron Robert B. (4130 Defender Dr. Agoura Hill CA 91303-3510), In vitro method for producing differentiated universally compatible mature human blood cells.
Bhagwat,Shripad S.; Satoh,Yoshitaka; Sakata,Steven T.; Buhr,Chris A.; Albers,Ronald; Sapienza,John; Plantevin,Veronique; Chao,Qi; Sahasrabudhe,Kiran; Ferri,Rachel, Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith.
Bhagwat,Shripad S.; Satoh,Yoshitaka; Sakata,Steven T.; Buhr,Chris A.; Albers,Ronald; Sapienza,John; Plantevin,Veronique; Chao,Qi; Sahasrabudhe,Kiran; Ferri,Rachel, Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith.
Prockop Darwin J. ; Pereira Ruth F. ; Leeper Dennis B. ; O'Hara Michael D., Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects.
Edward A. Boyse ; Hal E. Broxmeyer ; Gordon W. Douglas, Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood.
Boyse Edward A. (Tucson AZ) Broxmeyer Hal E. (Indianapolis IN) Douglas Gordon W. (New York NY), Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of the.
Sakata,Steven T.; Raymon,Heather K., Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto.
Sakata,Steven T.; Raymon,Heather K., Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related.
Pykett, Mark J.; Rosenzweig, Michael; Scadden, David T.; Poznansky, Mark C., Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices.
Kevin R. McIntosh ; Joseph D. Mosca ; Elena N. Klyushnenkova, Mesenchymal stem cells for prevention and treatment of immune responses in transplantation.
McIntosh Kevin R. ; Mosca Joseph D. ; Klyushnenkova Elena N., Mesenchymal stem cells for prevention and treatment of immune responses in transplantation.
McIntosh, Kevin R.; Mosca, Joseph D.; Klyushnenkova, Elena, Mesenchymal stem cells for prevention and treatment of immune responses in transplantation.
Caplan Arnold I. (1300 Oakridge Dr. Cleveland Heights OH 44121) Haynesworth Stephen E. (3643 Antisdale Rd. Cleveland Heights OH 44118), Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells.
Emerson Stephen G. (Ann Arbor MI) Clarke Michael F. (Ann Arbor MI) Palsson Bernhard O. (Ann Arbor MI), Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultur.
Caplan Arnold I. (1300 Oakridge Dr. Cleveland Heights OH 44121) Haynesworth Stephen E. (3643 Antisdale Rd. Cleveland Heights OH 44118), Method for treating connective tissue disorders.
Murray Lesley (San Jose CA) Sutherland D. Robert (Oakville CAX), Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby an.
Emerson Stephen G. (Ann Arbor MI) Clarke Michael F. (Ann Arbor MI) Palsson Bernhard O. (Ann Arbor MI) Schwartz Richard M. (Ann Arbor MI), Methods and compositions for the ex vivo replication of human hematopoietic stem cells.
Emerson Stephen G. ; Clarke Michael F. ; Palsson Bernhard O., Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 sec.
Fei Rui G. (Seattle WA) Heimfeld Shelly (Woodinville WA) Minshall Billy W. (Mill Creek WA) Berenson Ronald J. (Mercer Island WA), Methods and device for culturing human hematopoietic cells and their precursors.
Leon W. M. M. Terstappen ; Galla Chandra Rao ; Jonathan W. Uhr ; Emilian V. Racila ; Paul A. Liberti, Methods and reagents for the rapid and efficient isolation of circulating cancer cells.
Terstappen, Leon W. M. M.; Rao, Galla Chandra; Uhr, Jonathan W.; Racila, Emilian V.; Liberti, Paul A., Methods and reagents for the rapid and efficient isolation of circulating cancer cells.
Anderson David J. ; Shah Nirao M., Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-.beta. super family growth factors.
Csete Marie ; Doyle John ; Wold Barbara, Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells.
Palsson Bernhard O. (Ann Arbor MI) Armstrong R. Douglas (Ann Arbor MI) Clarke Michael F. (Ann Arbor MI) Emerson Stephen G. (Ann Arbor MI), Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture.
Emerson Stephen G. (Ann Arbor MI) Clarke Michael F. (Ann Arbor MI) Palsson Bernhard O. (Ann Arbor MI), Methods for the ex vivo replication of human stem cells and/or expansion of human progenitor cells.
Hill Beth Louise ; Rozler Elen ; Chen Benjamin P., Methods of obtaining compositions enriched for hematopoietic stem cells, antibodies for use therein, compositions derived therefrom and methods of use thereof.
Emerson Stephen G. (Ann Arbor MI) Clarke Michael F. (Ann Arbor MI) Palsson Bernhard O. (Ann Arbor MI), Methods, compositions and devices for growing human hematopoietic cells.
Palsson Bernhard O. ; Emerson Stephen G. ; Schwartz Richard M., Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells.
Hariri,Robert J.; Stirling,David I.; Moutouh De Parseval,Laure A.; Chan,Kyle W. H., Modulation of stem and progenitor cell differentiation, assays, and uses thereof.
Yannas Ioannis V. (Newton Center MA) Burke John F. (Belmont MA) Gordon Philip L. (Lexington MA) Huang Chor (Avon Lake OH), Multilayer membrane useful as synthetic skin.
Vyakarnam Murty N. ; Zimmerman Mark C. ; Scopelianos Angelo George ; Roller Mark B. ; Gorky David V., Porous tissue scaffoldings for the repair of regeneration of tissue.
Vyakarnam, Murty N.; Zimmerman, Mark C.; Scopelianos, Angelo George; Roller, Mark B.; Gorky, David V., Porous tissue scaffoldings for the repair or regeneration of tissue.
Boyse Edward A. (New York NY) Broxmeyer Hal E. (Indianapolis IN) Douglas Gordon W. (New York NY), Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood.
Bennett,Brydon L.; Bhagwat,Shripad S.; Manning,Anthony M.; Murray,Brion W.; O'Leary,Eoin C.; Satoh,Yoshitaka, Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto.
Stern David M. (Great Neck NY) Oz Mehmet C. (Fort Lee NJ) Nowygrod Roman (Teaneck NJ) Koga Shin (New York NY) Pinsky David J. (Riverdale NY), Solution for prolonged organ preservation.
Muller George W. ; Stirling David I. ; Chen Roger Shen-Chu ; Man Hon-Wah, Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNF.alpha. levels.
Muller George W. ; Stirling David I. ; Chen Roger Shen-Chu ; Man Hon-Wah, Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels.
George W. Muller ; David I. Stirling ; Roger Shen-Chu Chen, Substituted 2-(2,6-dioxopiperidin-3-yl)- phthalimides and 1-oxoisoindolines and method of reducing TNF.alpha. levels.
McIntosh, Kevin; Klyushnenkova, Elena, Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation.
Muller George W. ; Stirling David I. ; Chen Roger Shen-Chu, Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNF.alpha. levels.
Gerson Stanton L. (Pepper Pike OH) Caplan Arnold I. (Cleveland Heights OH) Haynesworth Stephen E. (Cleveland Heights OH), Transduced mesenchymal stem cells.
Hessel Stephen R. (Fountain Valley CA) Young H. Theodore (Lake Forest CA) Katz Michael (Richmond CA), Umbilical cord clamping, cutting, and blood collecting device and method.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.